United States · FDA National Drug Code directory
LAZCLUZE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 57894-240_da4a9239-16d7-46cf-b089-e943e0080015
- Product NDC
- 57894-240
- Form
- TABLET, FILM COATED
- Composition / generic term
- lazertinib
- Labeler
- Janssen Biotech, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20240820
- Source listing expiry
- 20271231
Source-listed ingredients
- LAZERTINIB — 240 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (57894-240-30) / 30 TABLET, FILM COATED in 1 BOTTLE · 57894-240-30
- 1 DOSE PACK in 1 CARTON (57894-240-99) / 14 TABLET, FILM COATED in 1 DOSE PACK · 57894-240-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →